Mercer Global Advisors Inc Guardant Health, Inc. Transaction History

Mercer Global Advisors Inc

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 15, 2022	BUY	$43.66 - $61.0 $215,898 - $301,645	4,945 New	4,945 $266,000
Q2 2022 Aug 10, 2022	SELL	$28.82 - $77.35 $145,483 - $390,462	-5,048 Closed	0 $0
Q1 2022 May 10, 2022	SELL	$48.25 - $100.49 $31,266 - $65,117	-648 Reduced 11.38%	5,048 $334,000
Q4 2021 Feb 04, 2022	BUY	$88.71 - $120.43 $75,314 - $102,245	849 Added 17.52%	5,696 $570,000
Q3 2021 Nov 10, 2021	BUY	$98.77 - $132.17 $20,840 - $27,887	211 Added 4.55%	4,847 $606,000
Q2 2021 Aug 10, 2021	BUY	$109.77 - $165.68 $2,085 - $3,147	19 Added 0.41%	4,636 $576,000
Q1 2021 May 11, 2021	BUY	$127.04 - $179.1 $586,543 - $826,904	4,617 New	4,617 $705,000
Q4 2020 Feb 12, 2021	SELL	$99.96 - $135.93 $239,504 - $325,688	-2,396 Closed	0 $0
Q3 2020 Dec 10, 2020	BUY	$80.32 - $111.8 $192,446 - $267,872	2,396 New	2,396 $268,000
Q3 2019 Nov 12, 2019	SELL	$62.59 - $110.3 $349,940 - $616,687	-5,591 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$63.94 - $91.11 $182,292 - $259,754	2,851 Added 104.05%	5,591 $483,000
Q1 2019 Apr 23, 2019	SELL	$34.3 - $97.98 $142,688 - $407,596	-4,160 Reduced 60.29%	2,740 $210,000
Q1 2019 Apr 12, 2019	BUY	$34.3 - $97.98 $236,669 - $676,062	6,900 New	6,900 $259,000

323

127M

844K

2.38M

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $3.14B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

Get notified when there are updates to the investment portfolio of Mercer Global Advisors Inc , based on Form 13F filings with the SEC.

Stay updated on Mercer Global Advisors Inc with notifications on news.